Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers.
Extension without change of a currently approved collection
No
Regular
10/08/2024
Requested
Previously Approved
36 Months From Approved
02/28/2025
6
4
540
360
138,900
92,600
Rule 17a-12 sets forth requirements for OTC derivatives dealers registered with the Commission to report financial and operational information to the Commission. Form X-17A-5IIB is the form used by OTC derivatives dealers to report this information.
US Code:
15 USC 78a
Name of Law: Securities Exchange Act of 1934
The estimated time burden increased from approximately 360 hours per year to approximately 540 hours per year and the estimated cost burden increased from approximately $92,600 per year to approximately $138,900 per year because the number of respondents subject to the rule increased from 2 to 3.
$0
No
No
No
No
No
No
No
Barry Huang 212 336-1063
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.